maatpharma
  • Home
  • About us
    • Investors
    • Team
    • Main co-founders
    • Board of directors
    • Our partnerships
    • Our Ecosystem
  • Microbiota as a Therapy
    • Gut Microbiota
    • Symbiosis
    • Dysbiosis
    • Fecal Microbiota Transfer-based drugs
    • Technology
    • Collaboration with MaaT Pharma
  • Pipeline
  • News & Press Releases
    • News
    • Press Releases
  • Contact & Careers
  • Playingcards
Select Page

MAY 2016

by admin | May 1, 2016 | Press Releases | 0 comments

We are pleased to announce that Benoît Levast joined MaaT Pharma as Clinical Project Leader   Read more 

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • MaaT Pharma Launches European Clinical Trial in Severe Acute Graft-versus-Host Disease for patients receiving allogeneic Hematopoietic Stem Cell Transplantation
  • Hervé Affagard on Europe1 Label Entreprise
  • Dr. Joël Doré, MaaT Pharma’s co-founder, received awards for his work
  • MaaT Pharma To Release First in Patients Data At The 2017 ASH Meeting On Autologous Fecal Microbiota Transfer And Restoration Of Microbiota Diversity
  • MaaT Pharma completes patient recruitment of its Odyssée clinical trial

Archives

  • March 2018
  • January 2018
  • December 2017
  • November 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • November 2016
  • September 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • November 2015
  • October 2015
  • September 2015
  • July 2015

Designed by Elegant Themes | Powered by WordPress